Alma Hybrid introduces three must-have laser technologies – a 10600 (CO2) laser, 1570nm laser and transepidermal delivery ultrasound technology – in one sophisticated platform.
Alma Hybrid is the first laser to combine both ablative fractionated CO2 and non-ablative 1570 erbium delivered simultaneously, offering a new and effective approach to skin rejuvenation and scar treatment.
At the heart of the Alma Hybrid platform is HyGrid™, Alma’s novel hybrid applicator, which facilitates a customised skin-program matrix for any desired combination of ablation vs non-ablation ratio within the treated area.
HyGrid™ enables practitioners to meet each and every patient’s specific treatment needs, as well as the desired balance between results timeline and downtime – offering endless options of ablative, non-ablative and thermal treatments for skin rejuvenation.
Alma Hybrid creates a unique synergistic effect by combining the power of three core energies: fractionated CO2 laser, 1570 erbium laser and IMPACT, its proprietary Trans Epidermal Delivery system.
The 10600 CO2 laser is an optimal blend of ablative, coagulative and thermal effects for efficient, highly precise focused or fractional laser treatments. The 15700nm laser is a powerful nonablative modulated fiber laser which creates a thermal effect that promotes new dermis synthesis while leaving the epidermis intact.
Finally, IMPACT for Trans Epidermal Delivery, Alma’s patented ultrasound technology, uses acoustic pressure to deliver pharmaceuticals and cosmeceuticals trans-epidermally to achieve enhanced results.
The Alma Hybrid sets a new gold standard for skin rejuvenation treatment, offering a superior drug delivery system and precise combination of wavelengths for effective treatments with reduced downtime.
Dr John Sullivan,
Dermatologist, Miranda, NSW
We’ve only had our Alma Hybrid for a few months but we are increasingly utilising the device for a broadening range of indications and patients.
The TED (transepidermal delivery) got our initial attention. This is an exciting area of change in dermatology to help us achieve better outcomes and also improve and expedite recovery.
The large treatment spot size, excellently designed handpiece and the ability to flexibly mix the power and benefits of CO2 ablative laser with a non-ablative laser were also deciding factors when we chose to invest in this device.
In our experience, the main benefits of the Alma Hybrid are improved patient tolerance and recovery. The handpiece has a cooling ring which has improved our patients’ tolerance of treatment compared with other CO2 laser devices, making treatments easier for both patients and practitioners. This has made repeat treatments easier and more popular; patients are also readily prepared to undergo a series of treatments with the better treatment tolerance and recovery.
Overall, the ability to combine CO2 through the same spot and/or alternate treatment beams of ablative and non-ablative laser has seen good clinical benefits but also is associated with a less eventful recovery period compared with traditional CO2 or ablative laser. There is also a lower threshold for us to recommend CO2 laser treatment, for example, our teenage acne scarring treatments.
The ability to mix CO2 and non- ablative laser and adjust settings has enhanced our ability to treat entire cosmetic units and feather edges for better clinical results
The TED or IMPACT handpiece has further enhanced our photodynamic therapy outcome for treating precancerous skin damage. We routinely use laser assisted delivery for this treatment and the IMPACT handpiece achieves more even and greater photophore skin absorption and activation. The TED component makes us think about what we can do each time to either enhance outcomes or speed or assist our patients’ recovery from their treatments.
CO2 laser is a mainstay for treating many types of scarring. Combining this with TED (and non-ablative) also helps us tailor treatment to different types of scaring, whether they are raised and irritable, associated with skin atrophy and tissue loss or loss of pigment.
The Alma Hybrid is quick to set up and the touchscreen menus provide a good guide for treatments but also allow great flexibility to adjust treatment. The handpiece is also a winner for both patients and practitioners for comfort of use and visualisation. Additionally, the Alma Hybrid has reduced the barrier for training new staff on CO2 laser.
It is still early days in our practice but so far feedback has been positive for a range of treatment indications – from photoageing to acne scar treatment and precancerous actinic damage. Tolerance of treatment and recovery have been a plus, particularly for those who have had ablative laser treatments in the past.
Dr Sarah Boxley,
Cosmetic Physician, Fremantle, WA
We have had the Alma Hybrid in our clinic for only a couple of months and it has already proven itself to be a fantastic choice. I perform a lot of fractional resurfacing laser treatments but was looking for a device with a combination of wavelengths that would enable me to address different skin concerns with a single treatment.
I chose this device not only because it filled a gap in my practice, but also because it offers the unique Impact system that allows effective transepidermal drug delivery. The IMPACT ultrasound attachment is a game-changer in terms of transepidermal drug delivery. In combination with the CO2, this part of the device is really impressing me.
The combination of CO2 and Erbium wavelengths, with the cold contact plate on the skin, deliver a virtually painless treatment. We are finding that we don’t need any topical anaesthetic or air-cooling system for the majority of patients.
The ability to mix and match the ablative and non-ablative wavelengths and energy delivery patterns means it is possible to customise each individual treatment, yet there are also pre-set modes for ease of use and safe delegating of treatments.
For me, the main benefits are the versatility and the ease of use. Having both wavelengths available through the same applicator, with the ability to customise the optimal ratio of each wavelength so that I can tailor my treatments to each individual’s needs, makes this device so easy to use. The painless delivery and minimal downtime really appeal to my patients, and the IMPACT system means we can turbo-charge results with drug delivery through the epidermis.
My main patient demographic is 40- to 65-year-old working women – a group seeking effective skin solutions but whose lifestyles don’t allow for downtime. With the Alma Hybrid, I can now offer this demographic effective resurfacing and skin rejuvenation with virtually no downtime and no discomfort.
Some of the treatments can be delegated to my staff, so the device is frequently in use and, because we don’t need anaesthetic, treatments are quicker than with other devices. Being able to utilise the Hybrid for darker skin types has also expanded the number of patients to whom we can offer these treatments.
My patients are loving it. Patients who have had treatments with other devices seem to be the most impressed – they are experiencing results beyond their expectations with far less downtime than they have had in the past. Having the Alma Hybrid in our clinic has also brought in a number of new patients who have searched for it by name and come to us specifically for this device.
The clinical results so far have exceeded my expectations and I am excited to see how much more we can do with it than with other laser devices.
Dr Natasha Cook,
Dermatologist, Darlinghurst, NSW
The Alma Hybrid has a long list of tremendous benefits compared with other lasers in its category. It is the first laser to combine both ablative fractionated CO2 and non-ablative 1570 erbium delivered simultaneously.
It’s highly effective and offers superior results whilst less painful and with less downtime than comparative devices. Each treatment can be designed based on skin type and amount of downtime.
